Table 1 Demographic and clinical characteristics of the study group.
Variables | CDL, mean ± SD (n = 40) | CCA, mean ± SD (n = 17) | PDAC, mean ± SD (n = 15) |
|---|---|---|---|
Age; years | 77.1 ± 9.4 | 77.5 ± 9.5 | 77.7 ± 9.3 |
Sex, male; n (%) | 25 (62.5) | 11 (64.7) | 5 (33.3) |
Total bilirubin; mg/dl | 5.4 ± 5.0 | 5.6 ± 5.1 | 5.5 ± 5.1 |
Aspartate aminotransferase (AST), IU/L | 227.1 ± 285.3 | 221.2 ± 276.5 | 220.2 ± 277.0 |
Alanine aminotransferase (ALT), IU/L | 236.8 ± 233.5 | 229.5 ± 226.5 | 226.8 ± 228 |
Alkaline phosphatase (ALP), U/L | 505.8 ± 564.6 | 533.1 ± 568.6 | 533.8 ± 571.1 |
γ-Glutamyl trans peptidase (γ-GTP), IU/L | 568.5 ± 558.5 | 601.0 ± 586.3 | 593.6 ± 570.7 |
C-reactive protein (CRP), mg/dl | 8.35 ± 7.5 | 7.92 ± 7.5 | 7.9 ± 7.0 |
White blood cells (WBCs) ×102/ul | 117.5 ± 74.7 | 110.3 ± 73.9 | 107.5 ± 63.9 |
